These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 37495073)

  • 81. Impairment in cognitive function in patients with axial spondyloarthritis and psoriatic arthritis.
    Kleinert S; Schuch F; Rapp P; Ronneberger M; Wendler J; Sternad P; Popp F; Bartz-Bazzanella P; von der Decken C; Karberg K; Gauler G; Wurth P; Späthling-Mestekemper S; Kuhn C; Englbrecht M; Vorbrüggen W; Adler G; Welcker M
    Rheumatol Int; 2023 Jan; 43(1):89-97. PubMed ID: 36441274
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Ixekizumab for treating ankylosing spondylitis.
    Kiwalkar S; Beier S; Deodhar A
    Immunotherapy; 2019 Oct; 11(15):1273-1282. PubMed ID: 31530049
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Associations between certolizumab pegol serum levels, anti-drug antibodies and treatment response in patients with inflammatory joint diseases: data from the NOR-DMARD study.
    Gehin JE; Goll GL; Warren DJ; Syversen SW; Sexton J; Strand EK; Kvien TK; Bolstad N; Lie E
    Arthritis Res Ther; 2019 Nov; 21(1):256. PubMed ID: 31783773
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Comparing symptoms, treatment patterns, and quality of life of ankylosing spondylitis and non-radiographic axial spondyloarthritis patients in the USA: findings from a patient and rheumatologist Survey.
    Hunter T; Sandoval D; Booth N; Holdsworth E; Deodhar A
    Clin Rheumatol; 2021 Aug; 40(8):3161-3167. PubMed ID: 33611647
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Different drug survival of first line tumour necrosis factor inhibitors in radiographic and non-radiographic axial spondyloarthritis: a multicentre retrospective survey.
    Lopalco G; Venerito V; Cantarini L; Emmi G; Salaffi F; Di Carlo M; Tafuri S; Gentileschi S; Di Scala G; Nivuori M; Cacciapaglia F; Galeazzi M; Lapadula G; Iannone F
    Clin Exp Rheumatol; 2019; 37(5):762-767. PubMed ID: 31025925
    [TBL] [Abstract][Full Text] [Related]  

  • 86. New developments in ankylosing spondylitis-status in 2021.
    Klavdianou K; Tsiami S; Baraliakos X
    Rheumatology (Oxford); 2021 Dec; 60(Suppl 6):vi29-vi37. PubMed ID: 34951921
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Clinical characteristics of axial spondyloarthritis patients in China: results from ChinaSpA, the Chinese Spondyloarthritis Registry.
    Su J; Wang R; Duan X; Wang Y; Wu Z; Yang M; Xu J; Fan W; Zhao C; Li Q; Wang X; Zhu J; Wu L; Li M; Zeng X
    Clin Exp Rheumatol; 2022 Mar; 40(3):544-550. PubMed ID: 33938794
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Pharmacologic treatment of psoriatic arthritis and axial spondyloarthritis with traditional biologic and non-biologic DMARDs.
    Soriano ER; Acosta-Felquer ML; Luong P; Caplan L
    Best Pract Res Clin Rheumatol; 2014 Oct; 28(5):793-806. PubMed ID: 25488785
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Early Disease Activity or Clinical Response as Predictors of Long-Term Outcomes With Certolizumab Pegol in Axial Spondyloarthritis or Psoriatic Arthritis.
    van der Heijde D; Deodhar A; Fleischmann R; Mease PJ; Rudwaleit M; Nurminen T; Davies O
    Arthritis Care Res (Hoboken); 2017 Jul; 69(7):1030-1039. PubMed ID: 27696727
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Two-year imaging outcomes from a phase 3 randomized trial of secukinumab in patients with non-radiographic axial spondyloarthritis.
    Braun J; Blanco R; Marzo-Ortega H; Gensler LS; Van den Bosch F; Hall S; Kameda H; Poddubnyy D; van de Sande M; van der Heijde D; Zhuang T; Stefanska A; Readie A; Richards HB; Deodhar A
    Arthritis Res Ther; 2023 May; 25(1):80. PubMed ID: 37194094
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Is the current ASAS expert definition of a positive family history useful in identifying axial spondyloarthritis? Results from the SPACE and DESIR cohorts.
    Ez-Zaitouni Z; Hilkens A; Gossec L; Berg IJ; Landewé R; Ramonda R; Dougados M; van der Heijde D; van Gaalen F
    Arthritis Res Ther; 2017 May; 19(1):118. PubMed ID: 28569222
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Classification criteria for psoriatic arthritis and ankylosing spondylitis/axial spondyloarthritis.
    Rudwaleit M; Taylor WJ
    Best Pract Res Clin Rheumatol; 2010 Oct; 24(5):589-604. PubMed ID: 21035082
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Baseline Characteristics and Treatment Response to Ixekizumab Categorised by Sex in Radiographic and Non-radiographic Axial Spondylarthritis Through 52 Weeks: Data from Three Phase III Randomised Controlled Trials.
    van der Horst-Bruinsma IE; de Vlam K; Walsh JA; Bolce R; Hunter T; Sandoval D; Zhu D; Geneus V; Soriano ER; Magrey M
    Adv Ther; 2022 Jun; 39(6):2806-2819. PubMed ID: 35429281
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Relevance of structural damage in the sacroiliac joints for the functional status and spinal mobility in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort.
    Protopopov M; Sieper J; Haibel H; Listing J; Rudwaleit M; Poddubnyy D
    Arthritis Res Ther; 2017 Oct; 19(1):240. PubMed ID: 29065931
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Procollagen I N-terminal peptide correlates with inflammation on sacroiliac joint magnetic resonance imaging in ankylosing spondylitis but not in non-radiographic axial spondyloarthritis: A cross-sectional study.
    Li X; Liang A; Chen Y; Lam NS; Long X; Xu X; Zhong S
    Mod Rheumatol; 2022 Jul; 32(4):770-775. PubMed ID: 34897520
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Relationship between sex and clinical and imaging features of early axial spondyloarthritis: results from a 48 month follow-up (Italian arm of the SPondyloArthritis Caught Early (SPACE) study).
    Lorenzin M; Cozzi G; Scagnellato L; Ortolan A; Vio S; Striani G; Scapin V; De Conti G; Doria A; Ramonda R
    Scand J Rheumatol; 2023 Sep; 52(5):519-529. PubMed ID: 36847124
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Prevalence of Nonradiographic Sacroiliitis in Patients With Psoriatic Arthritis: A Real-life Observational Study.
    Furer V; Levartovsky D; Wollman J; Wigler I; Paran D; Kaufman I; Elalouf O; Borok S; Anouk M; Sarbagil-Maman H; Berman M; Polachek A; Matz H; Flusser G; Druckmann I; Eshed I; Elkayam O
    J Rheumatol; 2021 Jul; 48(7):1014-1021. PubMed ID: 33452174
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Axial psoriatic arthritis and ankylosing spondylitis: same or different? A real-world study with emphasis on comorbidities.
    Fragoulis GE; Pappa M; Evangelatos G; Iliopoulos A; Sfikakis PP; Tektonidou MG
    Clin Exp Rheumatol; 2022 Jul; 40(7):1267-1272. PubMed ID: 34369366
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Axial Spondyloarthritis in Japan.
    Kameda H; Kishimoto M; Kobayashi S; Tomita T; Morita A; Yamamura M
    Curr Rheumatol Rep; 2022 May; 24(5):149-155. PubMed ID: 35380380
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Emerging drugs for the treatment of axial and peripheral spondyloarthritis.
    Braun J; Kiltz U; Heldmann F; Baraliakos X
    Expert Opin Emerg Drugs; 2015 Mar; 20(1):1-14. PubMed ID: 25575936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.